Evidence map›Paper›PMID 36409555›Full record

ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)2022

Gender differences in progression to crack-cocaine use and the role of sexual and physical violence.

Fernando Pezzini Rebelatto, Felipe Ornell, Vinícius Serafini Roglio, Breno Sanvicente-Vieira, Rodrigo Grassi-Oliveira, Flavio Pechansky, Felix Henrique Paim Kessler, Jaqueline Bohrer Schuch, Lisia von Diemen

Abstract read
In one paragraph

Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fernando Pezzini RebelattoCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Felipe OrnellCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Vinícius Serafini RoglioCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Breno Sanvicente-VieiraLaboratório de Pesquisa em Diferenças Individuais e Psicopatologia, Departamento de Psicologia, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Rodrigo Grassi-OliveiraDevelopmental Cognitive Neuroscience Lab, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Flavio PechanskyCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Felix Henrique Paim KesslerCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Jaqueline Bohrer SchuchCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.
Lisia von DiemenCentro de Pesquisa em Álcool e Drogas, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento (UFRGS), Porto Alegre, RS, Brazil.

Funding

CAPES 001CNPq 466802/2014-5 and 478492/2013-8FIPE/HCPA 2014-0249 and 2014-0395SENAD 822647/2015 and 08129.015636/2017-78
6 · The paper itself

Abstract

objectiveThis study aimed to evaluate whether progression from first drug use to crack-cocaine use differs according to gender, and whether the report of sexual or physical violence impacts the time of progression.

methodsWe interviewed 896 crack-cocaine users (548 men; 348 women) from addiction treatment units. Cox regression models evaluated the time of progression from first drug use to crack use. We analyzed gender differences according to the absence or presence of sexual or physical violence, also considering whether violence, when present, had occurred before or after the onset of crack use.

resultsWomen presented a faster progression to crack use regardless of exposure to sexual or physical violence (p < 0.05). Compared to unexposed men, there was a similar progression for men exposed to sexual or physical violence before the first use of crack (p = 0.167 and p = 0.393, respectively). In both genders, we observed a faster progression among individuals exposed to these types of violence after the onset of crack use (p < 0.01).

conclusionsWe found a faster progression to crack use among women and among individuals exposed to sexual and physical violence after the onset of crack use. These results encourage differentiated treatment strategies, focused on gender and individual characteristics.

Indexed as

Cocaine-Related DisordersCrack CocaineSubstance-Related DisordersFemaleHumansMalePhysical AbuseSex FactorsSexual BehaviorCrack Cocainecrack cocaineDrug addictiongender differencesphysical violencesexual violence

Identifiers

PMID36409555
PMCPMC9561837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.